Effects of androgen deprivation therapy on cognitive functions in patients with metastatic prostate cancer: A multicentric, prospective study of the Society of Urological Surgery Andrology group.
Ekrem AkdenizTahsin TuruncIlke Onur KazazÖmer YildirimHasan DeliktasAhmet CihanAhmet Gudelogluİyimser ÜreSerkan DeveciBahadir SahinBilge Piri CinarHamdi OzkaraPublished in: International journal of clinical practice (2021)
The ADT in patients with metastatic prostate cancer does not affect patients' cognitive functions and depressive symptoms. However, further prospective randomised studies with higher cohorts and longer follow-up periods are needed.
Keyphrases
- prostate cancer
- depressive symptoms
- radical prostatectomy
- end stage renal disease
- ejection fraction
- clinical trial
- newly diagnosed
- minimally invasive
- open label
- coronary artery bypass
- randomized controlled trial
- study protocol
- bone marrow
- patient reported outcomes
- atrial fibrillation
- acute coronary syndrome
- case control
- percutaneous coronary intervention